Structure Therapeutics Incorporation Aktie
WKN DE: A3D5Y7 / ISIN: US86366E1064
|
09.12.2025 01:55:22
|
Why Structure Therapeutics Stock Doubled and Then Some on Monday
Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure Therapeutics (NASDAQ: GPCR), skyrocketed almost 103% higher in price that day on some highly promising data produced by its weight-loss candidate medication. Structure, which concentrates on metabolic diseases with a particular focus on obesity, unveiled the topline data for its GLP-1 drug aleniglipron. The weight-loss treatment was put through its paces in a phase 2b study. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Structure Therapeutics Incorporation (spons. ADRs)mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Structure Therapeutics Incorporation (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
| Structure Therapeutics Incorporation (spons. ADRs) | 69,98 | 102,49% |
|